Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3108635 Target Snapshot

Arginase · SINGLE PROTEIN · Leishmania amazonensis

43Compounds
18Assays
2Approved Drugs
65.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt O96394. Use UniProt O96394 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O96394 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Arginase as ChEMBL target CHEMBL3108635, mapped to UniProt O96394. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Arginase
SINGLE PROTEIN · Leishmania amazonensis
As of 2026-09-14
ChEMBL target ID
CHEMBL3108635
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
O96394
Arginase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Arginase is the right protein anchor across sources, using UniProt O96394 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelArginase
UniProt AccessionO96394
Component TypeProtein
Sequence Length329 aa

Arginase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Arginase, mapped to UniProt O96394. Sequence length is 329 aa.

Mapped IDO96394
Review nameArginase
OrganismLeishmania amazonensis
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
6
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

IC5045.0
KI20.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL583912 6.7 Ki 200.0 Clinical
CHEMBL311498 6.22 Ki 600.0 Approved
CHEMBL444478 6.16 Ki 700.0 Clinical
CHEMBL3109443 6.05 IC50 900.0 Preclinical
CHEMBL3109443 6.05 Ki 900.0 Preclinical
CHEMBL164 5.92 Ki 1200.0 Preclinical
CHEMBL3098862 5.89 Ki 1300.0 Preclinical
CHEMBL4204512 5.89 Ki 1300.0 Preclinical
CHEMBL31574 5.85 IC50 1400.0 Clinical
CHEMBL583912 5.8 IC50 1600.0 Clinical
Distribution

pChEMBL Value Distribution

10
5.0
9
5.5
4
6.0
1
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

CIANIDANOL
CHEMBL311498
Approved 1977
Assay Landscape

Assay Landscape

18
Total Assays
37
Tested Compounds
1
Assay Types
Binding — 18 assays, 37 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 13 27 5.2
single protein format 5 10 5.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine